Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quadrant Laboratories, a subsidiary of Quadrant Biosciences, is a life sciences company focused on the development and implementation of epigenetic diagnostic tests. The company operates a CLIA-certified laboratory in Syracuse, New York, where it processes advanced molecular assays, most notably the Clarifi ASD test for autism spectrum disorder. This non-invasive saliva test utilizes a proprietary functional epigenetic analysis platform to identify RNA biomarkers associated with neurodevelopmental conditions. Beyond autism, the company has expanded its portfolio to include diagnostics for mild traumatic brain injury and Parkinson's disease, as well as large-scale infectious disease surveillance. Quadrant Laboratories gained significant prominence for its high-throughput COVID-19 saliva testing and wastewater monitoring programs during the global pandemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quadrant Laboratories.